Cordis Cites Stent Risk But Still Loses Patent Fight

Law360, New York (September 24, 2007, 12:00 AM EDT) -- A Johnson & Johnson Inc. subsidiary's attempt to overturn a patent infringement ruling based on new evidence alleging that its stents caused fatal blood clots has been denied by a Delaware federal judge, who ruled that the evidence was “too speculative” and “may well inflame” a jury.

Judge Sue L. Robinson on Monday dismissed motions by J&J unit Cordis Corp. which sought to overturn two findings of infringement on Boston Scientific Corp. patents for coronary stent patents. Robinson also entered final judgments that Boston Scientific and...
To view the full article, register now.